Huw M. Nash, COO & CBO at Stoke Therapeutics, Inc. (STOK), sold 50,000 shares at $15.39 ($770K) on 2024-05-20, disclosed to the SEC on 2024-05-22.
Scheduled sale ($770k) by COO & CBO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| STOK | SELL | 2024-03-19 | $25K | — | Filing → |
| STOK | SELL | 2022-01-05 | $88K | — | Filing → |
| STOK | SELL | 2021-12-03 | $139K | — | Filing → |